Erratum to "Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models"
- PMID: 35341139
- PMCID: PMC8956390
- DOI: 10.1155/2022/9808974
Erratum to "Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models"
Abstract
[This corrects the article DOI: 10.1155/2021/9911935.].
Copyright © 2022 Ya-Ya Yu et al.
Erratum for
-
Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models.Evid Based Complement Alternat Med. 2021 Oct 4;2021:9911935. doi: 10.1155/2021/9911935. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34646330 Free PMC article.
References
-
- Yu Y.-Y., Zhu Y.-J., Zou Y., et al. Qing-kai-ling injection acts better than shen-fu injection in enhancing the antitumor effect of Gefitinib in resistant non-small cell lung cancer models. Evidence-Based Complementary and Alternative Medicine . 2021;2021:14. doi: 10.1155/2021/9911935.9911935 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
